Sohn Conference Foundation and Academy to Hold International Conference on Treatment Strategies for Pediatric Cancer
Participants will discuss latest strategies to close gap between basic research and new treatments.
Published December 20, 2017
NEW YORK, December 20, 2017 — The Sohn Conference Foundation and the New York Academy of Sciences will jointly present the Sohn Conference: Accelerating Translation of Pediatric Cancer Research at The Royal Society* in London, United Kingdom. The dates of the conference are Monday, February 26 to Wednesday, February 28, 2018. As a follow-up to the 2016 Sohn Conference: Pediatric Cancer in a Post-genomic World, this symposium aims to advance the dialogue and discuss strategies that will help bridge the gap between basic research discoveries and new treatment approaches for pediatric and adolescent cancer patients.
Over the past decades, greater understanding of pediatric cancers has led to better insights into their causes, biology and patterns, such as the genetic distinction between some pediatric and adult cancers. Although mortality rates have declined significantly, cancer remains the leading cause of death from disease among children and adolescents in the United States and Europe. Rates of relapse remain high, 20 percent of pediatric cancer patients do not respond to therapy, and harsh treatment regimens often lead to adverse late-effects. To address these issues, more research and better treatment strategies are needed.
“The Sohn Conference Foundation brings together the best minds in the hedge fund industry to raise money for our cause of treating and curing pediatric cancer,” said Evan Sohn, Vice-President of the Sohn Conference Foundation. “In partnership with the New York Academy of Sciences, we are bringing together the best minds in pediatric cancer to advance that cause. We are proud to bring the Sohn Scientific Conference to London as a reflection of Sohn’s global expansion, which began in London.”
During this multi-day conference, international stakeholders, including researchers, clinicians, pediatric cancer advocates, and government and industry participants, will gather to share their findings, identify best practices, and unify their treatment approach across ten plenary sessions. The conference will include two keynote lectures featuring Richard Gilbertson, MD, PhD, of the Cancer Research UK Cambridge Institute at the University of Cambridge, and Mignon Loh, MD, Professor of Clinical Pediatrics at the University of California, San Francisco.
“The pediatric cancer community is very collaborative and well organized making it possible to rapidly share and discuss important scientific insights. Small size presents an opportunity to make insights,” said Prof. Gilbertson. “The Sohn Conference enables the leaders in the field to sit down together, to ask some very sensible questions, and plan routes forward.”
Interested parties are invited to register at this link.
About the Sohn Conference Foundation
The Sohn Conference Foundation is dedicated to the treatment and cure of pediatric cancer and other childhood diseases. The Foundation supports cutting-edge medical research, state-of-the-art research equipment, and innovative programs to ensure that children with cancer survive and thrive. The Foundation raises its funds through premier investment conferences and special events, including the renowned annual New York Sohn Investment Conference. Founded in 1995, the Conference honors the memory of Ira Sohn, a Wall Street Professional who lost his battle with cancer at age 29. The Foundation has expanded its reach to include the Sohn Australia Conference, Sohn Brazil Conference, Sohn Canada Conference, Sohn Hong Kong Conference, Sohn India Conference, Sohn London Conference, Sohn Monaco Conference, Sohn San Francisco Conference, Sohn Tel Aviv Conference, and Sohn Zurich Conference. To date, the Foundation has raised more than $80 million. More information on the Sohn Investment Conference is available at www.sohnconference.org.
The World’s Smartest Network®
The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science, technology, and society worldwide. With more than 20,000 members in 100 countries around the world, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at www.nyas.org.
* This event is not organized or endorsed by The Royal Society.